Showing results (1721-1730 of 2,343) with videos related to

Sort By:
Pageof 235
Epigenetics|June 2, 2016
Global assessment of imprinted gene expression in the bovine conceptus by next generation sequencingZhiyuan Chen, Darren E Hagen, Juanbin Wang, et al.
The American Journal of Cardiology|January 1, 1991
Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapyB R Brodie, R A Weintraub, T D Stuckey, et al.
Journal of Vascular Surgery|August 1, 1986
Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene graftsK J Hansen, H R Howe, T A Edgerton, et al.
Biology of Reproduction|March 1, 1987
Biochemical characterization and biosynthesis of the uterine milk proteins of the pregnant sheep uterusP J Hansen, N H Ing, R J Moffatt, et al.
Clinical Chemistry|January 1, 1989
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigenH J Hansen, G LaFontaine, E S Newman, et al.
Journal of Dairy Science|March 6, 2017
Association of single nucleotide polymorphisms in candidate genes previously related to genetic variation in fertility with phenotypic measurements of reproductive function in Holstein cowsM Sofia Ortega, Anna C Denicol, John B Cole, et al.
Vascular and Endovascular Surgery|December 14, 2004
Chronic visceral ischemia: symptom-free survival after open surgical repairWilliam P English, Jeffrey D Pearce, Timothy E Craven, et al.
Applied and Environmental Microbiology|February 5, 2005
Beringian paleoecology inferred from permafrost-preserved fungal DNAMagnus C Lydolph, Jonas Jacobsen, Peter Arctander, et al.
Annals of Vascular Surgery|January 9, 2004
Late-onset type II endoleaks and the incidence of secondary interventionChristopher J Hansen, Benjamin Kim, Ihab Aziz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphomaRhona Stein, Zhengxing Qu, Susan Chen, et al.
Pageof 235